
Please try another search
Noratis (DE:NUVG) remains firmly on a growth path. Accelerating development of its asset base (the stock book value was up by over half in H218 at €176m) was followed by news that fundraising...
Markets calm as FTSE fails to openRecession fears are alive and well but Friday is off to a more relaxed start, perhaps a sign that investors already have one eye on their weekend activities after a...
Introduction on Stock ValuationWhen it comes to writing about investing in common stocks, my favorite theme typically revolves around valuation. In fact, I once had a reader dub me “Mr....
The economic data on August 15 was good but what was even better was that GDPNow print from the Atlanta Fed that ticked up to 2.2%. Now, based on my prior work, GDPNow generally runs lighter than real...
Another terrific day! Even though we had ad bounce in the market, leading to a green ES and NQ, I turned out another nice profit, thanks to my well-chosen positions. I remain entirely short, and...
Jitters have well and truly set in and equity markets are suffering the consequences as investors head for safety in numbers. Every time investors find the strength to pick themselves up off the...
Pre-Open Market AnalysisYesterday was a strong bear trend day, and there was very little overlap with Tuesday, which was a strong bull day. This is a bull trap and it increases the chance of lower...
This chart looks at the performance of the S&P 500, crude oil and the Yield on the 10-year note over the past 4 months. Crude has declined about 14% more than the S&P 500 did...
Index Futures Net Changes and Settlements: Foreign Markets, Fair Value and Volume: In Asia 7 out of 11 markets closed lower: Shanghai Comp +0.25%, Hang Seng +0.76%, Nikkei...
In June, PDL BioPharma Inc (NASDAQ:PDLI) invested the second and final tranche of $30m ($60m in total) in Evofem, a women’s health company that is preparing to submit an NDA for Amphora, a...
All eyes will be on Facebook (NASDAQ:FB) this afternoon for clues as to whether investors are concerned about the latest data scandal to hit the tech giant. Facebook has been paying outside...
What if there was a way you could tap this market correction to grab the biggest S&P 500 stocks cheap—all while hedging your downside and getting a 7.2% dividend yield?It’s not only...
Assuming a successful FDA review of remimazolam for procedural sedation (PS), with an outcome due by 5 April 2020, Paion O.N (DE:PA8G) is set for 20–25% royalties from US sales made by Cosmo....
Bad Hair Days Are BackWe recently discussed the many divergences between major US indexes, which led us to expect that a downturn in the stock market was close (see The Calm Before the Storm for...
Reports Q2 2019 results on Thursday, Aug. 15, after the closeRevenue expectation: $2.55 billionEPS expectation: $1.14 The recent volatility in NVIDIA (NASDAQ:NVDA) shares signals a lot about what...